文献速递淋巴瘤

Wnt5a通过ROR1复合并激活皮质蛋白增强慢性淋巴细胞白血病细胞迁移

Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.
PubMed 文献 · Leukemia · 2018-12-19

研究发现Wnt5a处理慢性淋巴细胞白血病(CLL)细胞后,ROR1与皮质蛋白结合,使其Y421位点酪氨酸磷酸化,招募ARHGEF1并激活RhoA,从而增强白血病细胞迁移。该效应可被人源化抗ROR1单克隆抗体cirmtuzumab抑制。ROR1的脯氨酸富集域(PRD)是招募皮质蛋白所必需,其中P841A突变可阻断上述信号。

要点

  • Wnt5a诱导ROR1与皮质蛋白结合并使其Y421磷酸化,增强CLL细胞迁移。
  • ROR1的PRD结构域介导皮质蛋白招募,P841位点是关键。
  • cirmtuzumab可抑制Wnt5a/ROR1依赖的CLL细胞迁移效应。

核心结论

  • 皮质蛋白在ROR1依赖的Wnt5a增强CLL细胞迁移中发挥重要作用。

研究设计与样本

  • 使用CLL细胞系MEC1转染全长ROR1或多种突变型ROR1,并生成在ROR1-PRD潜在SH3结合位点784、808、826、841或850位将脯氨酸(P)替换为丙氨酸(A)的单氨基酸突变MEC1细胞。

主要发现

  • Wnt5a处理CLL细胞后,ROR1与皮质蛋白结合,皮质蛋白Y421位点发生酪氨酸磷酸化,招募ARHGEF1并激活RhoA,增强白血病细胞迁移,该效应可被cirmtuzumab抑制。
  • ROR1的脯氨酸富集域(PRD)是招募皮质蛋白所必需。
  • 与野生型ROR1或其他ROR1 P→A突变体不同,ROR1 P841A突变体在Wnt5a刺激下不能与皮质蛋白或ARHGEF1形成复合物。
  • Wnt5a不能诱导MEC1-ROR1 P841A细胞磷酸化皮质蛋白或增强CLL细胞F-肌动蛋白聚合。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic lymphocytic leukemia cells (CLL) migrate between the blood and lymphoid tissues in response to chemokines. Such migration requires structured cytoskeletal-actin polymerization, which may involve the protein cortactin. We discovered that treatment of CLL cells with Wnt5a causes Receptor tyosin kinase-like orphan receptor 1 (ROR1) to bind cortactin, which undergoes tyrosine phosphorylation at Y421, recruits ARHGEF1, and activates RhoA, thereby enhancing leukemia-cell migration; such effects could be inhibited by cirmtuzumab, a humanized mAb specific for ROR1. We transfected the CLL-cell-line MEC1 with either full-length ROR1 or various mutant forms of ROR1 to examine the structural features required for binding cortactin. We found that the proline-rich domain (PRD) was necessary for ROR1 to recruit cortactin. We generated MEC1 cells that each expressed a mutant form of ROR1 with a single amino-acid substitution of alanine (A) for proline (P) in potential SH3-binding sites in the ROR1-PRD at positions 784, 808, 826, 841, or 850. In contrast to wild-type ROR1, or other ROR1P=>A mutants, ROR1P(841)A failed to complex with cortactin or ARHGEF1 in response to Wnt5a. Moreover, Wnt5a could not induce MEC1-ROR1P(841)A to phosphorylate cortactin or enhance CLL-cell F-actin polymerization. Taken together, these studies show that cortactin plays an important role in ROR1-dependent Wnt5a-enhanced CLL-cell migration.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Hasan MK, Rassenti L, Widhopf GF, et al. Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells. Leukemia. 2018. PMID: 30568170. doi:10.1038/s41375-018-0306-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。